葛根麻黄汤治疗毒邪犯肺证流行性感冒的临床效果
CSTR:
作者:
作者单位:

作者简介:

周春游,男,主管中药师,主要研究方向是中药学。

通讯作者:

中图分类号:

R 373.1+ 3

基金项目:


Clinical effect of Pueraria mahuang Decoction in treating influenza with pulmonary syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:分析葛根麻黄汤加减在毒邪犯肺证流行性感冒的临床效果。 方法:按照 1:1 原则和随机数字表法 将永春县湖洋中心卫生院 2022 年 2 月至 2022 年 7 月期间收治的 100 例风寒湿疫毒所致流行性感冒患者分为两组, 各 50 例。西医组患者给予常规西医治疗,在此基础上中医组患者给予葛根麻黄汤加减。比较两组患者临床疗效、症 状改善情况、炎症指标、免疫功能、不良反应。 结果:中医组患者治疗总有效率为 96.00 %,高于西医组的 84.00 %, 差异具有统计学意义(P < 0.05)。中医组患者咳嗽、咽痛、鼻塞流涕消失时间均明显短于西医组,差异具有统计学 意义(P < 0.05)。两组患者的退热时间比较,差异无统计学意义(P > 0.05)。治疗后两组患者的血清白细胞介素 –6 (IL–6)、IL–17、超敏 C 反应蛋白(hs–CRP)水平均有不同程度下降,且治疗后中医组患者血清 IL–6、IL–17、 hs–CRP 水平均低于西医组,差异具有统计学意义(P < 0.05)。治疗后两组患者的 CD3+ 、CD4+ 、CD4+ /CD8+ 均有 不同程度提高,且治疗后中医组患者 CD3+ 、CD4+ 、CD4+ /CD8+ 均高于西医组,差异具有统计学意义(P < 0.05)。 两组患者不良反应发生率比较,差异无统计学意义(P > 0.05)。结论:葛根麻黄汤加减治疗能有效改善毒邪犯肺证 流行性感冒患者免疫功能,抑制炎症反应,减轻临床症状,且具有一定安全性。

    Abstract:

    AbstractObjective To analyze the clinical effect of Gegen Mahuang decoction in the treatment of influenza with pulmonary syndrome caused by toxic pathogens. Methods According to the 1:1 principle and random number table method, 100 cases of influenza caused by wind-cold and dampdamp-related virus admitted to Huyang Central Health Center of Yongchun County from February 2022 to July 2022 were divided into two groups, with 50 cases each. The Western medicine group was given conventional Western medicine treatment, on the basis of which the Chinese medicine group was given pueraria ephedra decoction plus or minus. The clinical efficacy, symptom improvement, inflammatory indicators, immune function and adverse reactions were compared between the two groups. Results The total effective rate of the TCM group was 96.00 %, higher than that of the Western group (84.00 %), and the difference was statistically significant (P < 0.05).The disappearance time of cough, sore throat, nasal congestion and runny nose in TCM group was significantly shorter than that in Western group, the difference was statistically significant (P < 0.05). There was no statistical significance in the time of fever reduction between the two groups (P > 0.05).After treatment, the serum levels of interleukin-6 (IL-6), IL-17, and hypersensitive C-reactive protein (hs-CRP) in the two groups were decreased to varying degrees, and the serum levels of IL-6, IL-17, hs-CRP in the Chinese medicine group were lower than those in the Western medicine group after treatment, the difference was statistically significant (P < 0.05).After treatment, the CD3+ , CD4+ , CD4+ /CD8+ of the two groups were improved to varying degrees, and after treatment, the CD3+ , CD4+ , CD4+ /CD8+ of the Chinese medicine group were higher than those of the Western medicine group, the difference was statistically significant (P < 0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion The modified and modified treatment of Pueraria Mahuang decoction can effectively improve the immune function, inhibit the inflammatory response and reduce clinical symptoms in the patients with influenza with pulmonary syndrome caused by toxic pathogens. The efficacy is accurate and has certain safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-11-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-06-08
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭